Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Neurology | Psychiatry/Psychology | Pediatrics/Neonatology | Family Medicine
Disease Category: Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)
Location: United States, CA

Trial Information

Is your teen struggling with symptoms of ADHD?

Peninsula Research Associates is conducting an ADHD trial that is testing two different medications, Vyvanse™ and Concerta™, which are both FDA approved and commonly used to treat ADHD. Study participation requires approximately 8 - 10 visits over the course of about 11 – 13 weeks.

Qualified participants may receive up to $250.00 compensation for time and travel.

Study related procedures are provided at no charge, including:

  • ADHD assessment
  • Confidential study related physical exams and laboratory services
  • Study medication
  • One-on-one, private physician visits
  • Study follow-up
  • Flexible appointment hours

Patient Inclusion Criteria

  • Be male or female, aged 13-17 years.
  • Be diagnosed with ADHD or have symptoms of ADHD.

Patient Exclusion Criteria

  • History of substance abuse
  • Has taken taken part in a clinical study within the past 30 days
  • Females who are pregnant or lactating

Peninsula Research Associates
550 Deep Valley Drive, Suite 317
Rolling Hills Estates, CA 90274
Phone: 310-265-1623
Fax: 310-265-1753
Email: info@PeninsulaResearch.com

View Map

Research Center Information: Peninsula Research Associates

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.